Meeting
2020 Gastrointestinal Cancers Symposium
Impact of CDKN2A/b status in pancreatic cancer (PC).
Authors
Kaitlin Annunzio
Medical College of Wisconsin, Milwaukee, WI
Kaitlin Annunzio , Claire Griffiths , Igli Arapi , Matthew Lasowski , Arun K. Singavi , Kulwinder Dua , Abdul H. Khan , Paul S. Ritch , Mandana Kamgar , James P. Thomas , William Adrian Hall , Beth Erickson , Susan Tsai , Kathleen K. Christians , Douglas B. Evans , Raul Urrutia , Aniko Szabo , Ben George
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 759)
Abstract #
759
Poster Bd #
N4
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
First Author: Kumiko Umemoto
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2020 Gastrointestinal Cancers Symposium
Detection of circulating tumor DNA in pancreas cancer.
First Author: Daniel King